162 related articles for article (PubMed ID: 3965404)
1. Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.
DiRienzo JM; Tsai CC; Shenker BJ; Taichman NS; Lally ET
Infect Immun; 1985 Jan; 47(1):31-6. PubMed ID: 3965404
[TBL] [Abstract][Full Text] [Related]
2. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.
Tsai CC; Shenker BJ; DiRienzo JM; Malamud D; Taichman NS
Infect Immun; 1984 Feb; 43(2):700-5. PubMed ID: 6319288
[TBL] [Abstract][Full Text] [Related]
3. Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.
Spitznagel J; Kraig E; Kolodrubetz D
Infect Immun; 1991 Apr; 59(4):1394-401. PubMed ID: 2004819
[TBL] [Abstract][Full Text] [Related]
4. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients.
Califano JV; Pace BE; Gunsolley JC; Schenkein HA; Lally ET; Tew JG
Oral Microbiol Immunol; 1997 Feb; 12(1):20-6. PubMed ID: 9151640
[TBL] [Abstract][Full Text] [Related]
5. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Kalfas S
Eur J Oral Sci; 2003 Jun; 111(3):209-15. PubMed ID: 12786951
[TBL] [Abstract][Full Text] [Related]
6. Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface.
Ohta H; Kato K; Kokeguchi S; Hara H; Fukui K; Murayama Y
Infect Immun; 1991 Dec; 59(12):4599-605. PubMed ID: 1937819
[TBL] [Abstract][Full Text] [Related]
7. Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.
Iwase M; Lally ET; Berthold P; Korchak HM; Taichman NS
Infect Immun; 1990 Jun; 58(6):1782-8. PubMed ID: 2341178
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
[TBL] [Abstract][Full Text] [Related]
9. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans.
Claesson R; Johansson A; Belibasakis G; Hänström L; Kalfas S
J Periodontal Res; 2002 Oct; 37(5):353-9. PubMed ID: 12366858
[TBL] [Abstract][Full Text] [Related]
10. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
[TBL] [Abstract][Full Text] [Related]
11. Lack of lipoprotein-dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Kalfas S
APMIS; 2002 Dec; 110(12):857-62. PubMed ID: 12645663
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.
Kolodrubetz D; Dailey T; Ebersole J; Kraig E
Infect Immun; 1989 May; 57(5):1465-9. PubMed ID: 2707855
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora.
Johansson A; Hänström L; Kalfas S
Oral Microbiol Immunol; 2000 Aug; 15(4):218-25. PubMed ID: 11154406
[TBL] [Abstract][Full Text] [Related]
14. Purification and quantification of Fusobacterium necrophorum leukotoxin by using monoclonal antibodies.
Tan ZL; Nagaraja TG; Chengappa MM; Staats JJ
Vet Microbiol; 1994 Nov; 42(2-3):121-33. PubMed ID: 7886927
[TBL] [Abstract][Full Text] [Related]
15. Systemic antibodies to the leukotoxin of the oral pathogen Actinobacillus actinomycetemcomitans correlate negatively with stroke in women.
Johansson A; Johansson I; Eriksson M; Ahrén AM; Hallmans G; Stegmayr B
Cerebrovasc Dis; 2005; 20(4):226-32. PubMed ID: 16123541
[TBL] [Abstract][Full Text] [Related]
16. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Sandström G; Kalfas S
J Periodontal Res; 2000 Apr; 35(2):85-92. PubMed ID: 10863962
[TBL] [Abstract][Full Text] [Related]
17. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin.
Simpson DL; Berthold P; Taichman NS
Infect Immun; 1988 May; 56(5):1162-6. PubMed ID: 3258584
[TBL] [Abstract][Full Text] [Related]
18. Association of Actinobacillus actinomycetemcomitans leukotoxin with nucleic acids on the bacterial cell surface.
Ohta H; Hara H; Fukui K; Kurihara H; Murayama Y; Kato K
Infect Immun; 1993 Nov; 61(11):4878-84. PubMed ID: 8406888
[TBL] [Abstract][Full Text] [Related]
19. Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin.
Engström PE; George M; Larsson P; Lally ET; Taichman NS; Norhagen G
Oral Microbiol Immunol; 1999 Apr; 14(2):104-8. PubMed ID: 10219169
[TBL] [Abstract][Full Text] [Related]
20. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Infect Immun; 2000 Nov; 68(11):6094-100. PubMed ID: 11035711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
